USE OF VEGF ANTAGONIST FOR TREATING RETINOPATHY OF PREMATURITY

摘要

FIELD: medicine.;SUBSTANCE: invention relates to the use of ranibizumab in the treatment of pathological neovascularization of the retina of infants. This method for the treatment of infants with retinopathy of prematurity (ROP) includes the introduction of ranibizumab into the eye of a child in a dose of less than 0.25 mg.;EFFECT: invention provides treatment of infants with retinopathy of prematurity due to optimally selected doses of ranibizumab.;8 cl, 3 dwg, 6 ex